Skip to main content
Erschienen in: Neurological Sciences 1/2022

20.10.2021 | COVID-19 | COVID-19 Zur Zeit gratis

Screening for cognitive sequelae of SARS-CoV-2 infection: a comparison between the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA)

verfasst von: Edoardo Nicolò Aiello, Elena Fiabane, Marina Rita Manera, Alice Radici, Federica Grossi, Marcella Ottonello, Debora Pain, Caterina Pistarini

Erschienen in: Neurological Sciences | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Due to SARS-CoV-2-related encephalopathic features, COVID-19 patients may show cognitive sequelae that negatively affect functional outcomes. However, although cognitive screening has been recommended in recovered individuals, little is known about which instruments are suitable to this scope by also accounting for clinical status. This study thus aimed at comparatively assessing the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) in detecting cognitive deficits in post-COVID-19 patients premorbidly/contextually being or not at risk for cognitive deficits (RCD + ; RCD-).

Methods

Data from N = 100 COVID-19-recovered individuals having been administered both the MMSE and the MoCA were retrospectively analyzed separately for each group. RCD ± classification was performed by taking into consideration both previous and disease-related conditions. Equivalent scores (ESs) were adopted to examine classification performances of the two screeners.

Results

The two groups were comparable as for most background and cognitive measures. MMSE or MoCA adjusted scores were mostly unrelated to disease-related features. The two screeners yielded similar estimates of below-cut-off performances—RCD + : MMSE: 20%, MoCA: 23.6%; RCD-: MMSE: 2.2%, MoCA: 4.4%. However, agreement rates dropped when also addressing borderline, “low-end” normal, and normal ability categories—with the MoCA attributing lower levels than the MMSE (RCD + : Cohen’s k = .47; RCD-: Cohen’s k = .17).

Discussion

Although both the MMSE and the MoCA proved to be equally able to detect severe cognitive sequelae of SARS-CoV-2 infection in both RCD + and RCD- patients, the MoCA appeared to be able to reveal sub-clinical defects and more sharply discriminate between different levels of ability.
Literatur
1.
Zurück zum Zitat Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T (2020) Neurological associations of COVID-19. The Lancet Neurology 19:767–783 Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T (2020) Neurological associations of COVID-19. The Lancet Neurology 19:767–783
2.
Zurück zum Zitat Daroische R, Hemminghyth MS, Eilertsen TH, Breitve MH, Chwiszczuk LJ (2021) Cognitive impairment after COVID-19 - a review on objective test data. Front Neurol 12:1238CrossRef Daroische R, Hemminghyth MS, Eilertsen TH, Breitve MH, Chwiszczuk LJ (2021) Cognitive impairment after COVID-19 - a review on objective test data. Front Neurol 12:1238CrossRef
3.
Zurück zum Zitat Wilson BA, Betteridge S, Fish J (2020) Neuropsychological consequences of COVID-19. Neuropsychol Rehabil 30:1625–1628CrossRef Wilson BA, Betteridge S, Fish J (2020) Neuropsychological consequences of COVID-19. Neuropsychol Rehabil 30:1625–1628CrossRef
4.
Zurück zum Zitat Pistarini C, Fiabane E, Houdayer E, Vassallo C, Manera MR, Alemanno F (2021) Cognitive and emotional disturbances due to COVID-19: an exploratory study in the rehabilitation setting. Front Neurol 12:643646CrossRef Pistarini C, Fiabane E, Houdayer E, Vassallo C, Manera MR, Alemanno F (2021) Cognitive and emotional disturbances due to COVID-19: an exploratory study in the rehabilitation setting. Front Neurol 12:643646CrossRef
5.
Zurück zum Zitat Capitani E, Laiacona M (2017) Outer and inner tolerance limits: their usefulness for the construction of norms and the standardization of neuropsychological tests. Clin Neuropsychol 31:1219–1230CrossRef Capitani E, Laiacona M (2017) Outer and inner tolerance limits: their usefulness for the construction of norms and the standardization of neuropsychological tests. Clin Neuropsychol 31:1219–1230CrossRef
6.
Zurück zum Zitat Aiello EN, Gramegna C, Esposito A, Gazzaniga V, Zago S, Difonzo T, Maddaluno O, Appollonio I, Bolognini N (2021) The Montreal Cognitive Assessment (MoCA): updated norms and psychometric insights into adaptive testing from healthy individuals in Northern Italy. Aging Clin Exp Res 1–8. https://doi.org/10.1007/s40520-021-01943-7 Aiello EN, Gramegna C, Esposito A, Gazzaniga V, Zago S, Difonzo T, Maddaluno O, Appollonio I, Bolognini N (2021) The Montreal Cognitive Assessment (MoCA): updated norms and psychometric insights into adaptive testing from healthy individuals in Northern Italy. Aging Clin Exp Res 1–8. https://​doi.​org/​10.​1007/​s40520-021-01943-7
7.
Zurück zum Zitat Carpinelli Mazzi M, Iavarone A, Russo G, Musella C, Milan G, D’Anna F, Garofalo E, Chieffi S, Sannino M, Illario M, De Luca V (2020) Mini-Mental State Examination: new normative values on subjects in Southern Italy. Aging Clin Exp Res 32:699–702CrossRef Carpinelli Mazzi M, Iavarone A, Russo G, Musella C, Milan G, D’Anna F, Garofalo E, Chieffi S, Sannino M, Illario M, De Luca V (2020) Mini-Mental State Examination: new normative values on subjects in Southern Italy. Aging Clin Exp Res 32:699–702CrossRef
8.
Zurück zum Zitat Sim J, Wright CC (2005) The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther 85:257–268CrossRef Sim J, Wright CC (2005) The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther 85:257–268CrossRef
9.
Zurück zum Zitat Blazhenets G, Schröter N, Bormann T, Thurow J, Wagner D, Frings L, Weiller C, Meyer PT, Dressing A, Hosp JA (2021) Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients. J Nucl Med 62(7):910–915CrossRef Blazhenets G, Schröter N, Bormann T, Thurow J, Wagner D, Frings L, Weiller C, Meyer PT, Dressing A, Hosp JA (2021) Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients. J Nucl Med 62(7):910–915CrossRef
10.
Zurück zum Zitat Miskowiak KW, Johnsen S, Sattler SM, Nielsen S, Kunalan K, Rungby J, Lapperre T, Porsberg CM (2021) Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables. Eur Neuropsychopharmacol 46:39–48CrossRef Miskowiak KW, Johnsen S, Sattler SM, Nielsen S, Kunalan K, Rungby J, Lapperre T, Porsberg CM (2021) Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables. Eur Neuropsychopharmacol 46:39–48CrossRef
Metadaten
Titel
Screening for cognitive sequelae of SARS-CoV-2 infection: a comparison between the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA)
verfasst von
Edoardo Nicolò Aiello
Elena Fiabane
Marina Rita Manera
Alice Radici
Federica Grossi
Marcella Ottonello
Debora Pain
Caterina Pistarini
Publikationsdatum
20.10.2021
Verlag
Springer International Publishing
Schlagwort
COVID-19
Erschienen in
Neurological Sciences / Ausgabe 1/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-021-05630-3

Weitere Artikel der Ausgabe 1/2022

Neurological Sciences 1/2022 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.